CATALYST DOSSIER · UPDATED 2026-11-09
$ENGS
Unclassified · convergence 6 · conviction ELEVATED
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $ENGS?
Quantitative
Short scanner score : 6 (1 signals · 1 bearish forms YoY)
Catalysts
Dilution / supply forms : Recent SEC filings: NT-20-F — bearish supply signal
Short scanner signals : NT-20-F (+6)
Risks
Squeeze risk : Short positions exposed to overnight gap-up squeezes
Hard-to-borrow tail : Bearish setups on RegSHO threshold names face borrow-rate spikes and recall risk
Bear case
Bullish surprise (short-thesis failure) : Issuer announcement could reverse the supply narrative overnight
Sector rotation tailwind : Sector group bid in a risk-on day means even weak names rally — short timing matters
Sympathy basket (cerebro)
ACRE via financials r=+0.00 score-cohort (score 27)
SKYD via comms r=+0.00 score-cohort (score 27)
QBTS via tech r=+0.00 score-cohort (score 26)
NTST via financials r=+0.00 score-cohort (score 25)
CIIT via tech r=+0.00 score-cohort (score 24)
AORT via biotech r=+0.00 score-cohort (score 24)
Signals Firing
NT-20-F (+6)
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-11-03 sec_top_gappers +2.0% -0.7% — 2026-11-03 sec_top_moat_emerging +2.0% -0.7% — 2026-11-02 sec_top_gappers +0.4% -0.7% — 2026-11-02 sec_top_moat_emerging +0.4% -0.7% — 2026-10-30 sec_top_gappers +1.8% +1.3% — 2026-10-30 sec_top_moat_emerging +1.8% +1.3% —
Lifetime: 0/6 wins · hit-rate 0.0% on +2% intraday
Sympathy Basket ACRE via financials · score 27 SKYD via comms · score 27 QBTS via tech · score 26 NTST via financials · score 25 CIIT via tech · score 24 AORT via biotech · score 24
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.